Back to User profile » Dr Chaojie Liang
Papers published by Dr Chaojie Liang:
The Prognostic Value of LINC01296 in Pan-Cancers and the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation [Retraction]
Liang C, Zhang Y, Zhang Y, Li R, Wang Z, Wei Z, Guo J
OncoTargets and Therapy 2020, 13:2525-2526
Published Date: 26 March 2020
The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions in Gastric Cancer by Targeting the miR-302b-3p/E2F Transcription Factor 3 Axis [Retraction]
Liang C, Yue C, Liang C, Ge H, Wei Z, Li G, Wu J, Huang H, Guo J
OncoTargets and Therapy 2020, 13:2523-2524
Published Date: 26 March 2020
DUXAP8 a Pan-Cancer Prognostic Marker Involved in the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation
Yue C, Liang C, Li P, Yan L, Zhang D, Xu Y, Wei Z, Wu J
OncoTargets and Therapy 2019, 12:11637-11650
Published Date: 31 December 2019
The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions In Gastric Cancer By Targeting The miR-302b-3p/E2F Transcription Factor 3 Axis
Liang C, Yue C, Liang C, Ge H, Wei Z, Li G, Wu J, Huang H, Guo J
OncoTargets and Therapy 2019, 12:8879-8893
Published Date: 30 October 2019
The prognostic value of LINC01296 in pan-cancers and the molecular regulatory mechanism in hepatocellular carcinoma: a comprehensive study based on data mining, bioinformatics, and in vitro validation
Liang C, Zhang Y, Zhang Y, Li R, Wang Z, Wei Z, Guo J
OncoTargets and Therapy 2019, 12:5861-5885
Published Date: 19 July 2019
Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma
Yue C, Liang C, Ge H, Yan L, Xu Y, Li G, Li P, Wei Z, Wu J
OncoTargets and Therapy 2019, 12:4555-4566
Published Date: 11 June 2019
Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma
Yue C, Ren Y, Ge H, Liang C, Xu Y, Li G, Wu J
OncoTargets and Therapy 2019, 12:561-576
Published Date: 14 January 2019
Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis
Liang C, Zhao J, Ge H, Li G, Wu J
OncoTargets and Therapy 2018, 11:3561-3571
Published Date: 19 June 2018
Role of Beclin1 expression in patients with hepatocellular carcinoma: a meta-analysis
Liang C, Li W, Ge H, Zhang KT, Li GM, Wu J
OncoTargets and Therapy 2018, 11:2387-2397
Published Date: 27 April 2018
The clinicopathological and prognostic value of HSP27 in hepatocellular carcinoma: a systematic review and meta-analysis
Liang CJ, Xu YC, Ge H, Li GM, Wu JX
OncoTargets and Therapy 2018, 11:1293-1303
Published Date: 7 March 2018
Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma
Liang CJ, Xu Y, Ge H, Li G, Wu J
OncoTargets and Therapy 2018, 11:1203-1214
Published Date: 5 March 2018
Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis
Liang CJ, Xu YC, Ge H, Li GM, Wu JX
OncoTargets and Therapy 2018, 11:47-57
Published Date: 21 December 2017
Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis
Liang CJ, Xu YC, Li GM, Zhao TJ, Xia F, Li GQ, Zhang D, Wu JX
OncoTargets and Therapy 2017, 10:417-428
Published Date: 18 January 2017